United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
529.17
+51.01 (10.67%)
At close: Mar 9, 2026, 4:00 PM EDT
533.00
+3.83 (0.72%)
After-hours: Mar 9, 2026, 7:59 PM EDT
United Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 1,335 | 1,195 | 984.8 | 727.3 | 475.8 | Upgrade
|
| Depreciation & Amortization | 85.6 | 72.5 | 53.2 | 51.3 | 49.9 | Upgrade
|
| Asset Writedown & Restructuring Costs | 21.7 | - | 3.6 | 11.2 | 132.6 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | -5.4 | -90.3 | Upgrade
|
| Stock-Based Compensation | 147.7 | 144 | 39.1 | 106.8 | 138.5 | Upgrade
|
| Other Operating Activities | 78 | -88.4 | -69.3 | 52.5 | 65.9 | Upgrade
|
| Change in Accounts Receivable | -70.9 | -0.4 | -58.5 | -21.7 | -41.3 | Upgrade
|
| Change in Inventory | -52.6 | -46.9 | -13.6 | -13.4 | -7.5 | Upgrade
|
| Change in Accounts Payable | 97.9 | 42.7 | 57.1 | 44.5 | -12.5 | Upgrade
|
| Change in Other Net Operating Assets | -80.9 | 8.5 | -18.4 | -150.6 | -112.9 | Upgrade
|
| Operating Cash Flow | 1,561 | 1,327 | 978 | 802.5 | 598.2 | Upgrade
|
| Operating Cash Flow Growth | 17.64% | 35.70% | 21.87% | 34.15% | -20.84% | Upgrade
|
| Capital Expenditures | -520.5 | -246.5 | -230.4 | -138.8 | -120.8 | Upgrade
|
| Cash Acquisitions | - | - | -89.2 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -5.5 | - | - | - | - | Upgrade
|
| Investment in Securities | -14.9 | 692.2 | -377 | -676.2 | -366.1 | Upgrade
|
| Other Investing Activities | -10.4 | -28.5 | -23 | 3.5 | - | Upgrade
|
| Investing Cash Flow | -551.3 | 417.2 | -719.6 | -811.5 | -486.9 | Upgrade
|
| Long-Term Debt Issued | 200 | - | - | 800 | - | Upgrade
|
| Long-Term Debt Repaid | -500 | -400 | -100 | -800 | - | Upgrade
|
| Net Debt Issued (Repaid) | -300 | -400 | -100 | - | - | Upgrade
|
| Issuance of Common Stock | 183.1 | 160.1 | 104.6 | 94.3 | 55.6 | Upgrade
|
| Repurchase of Common Stock | -1,022 | -1,012 | -13.8 | -11.4 | -10.8 | Upgrade
|
| Other Financing Activities | -11.5 | -2.7 | -2.7 | -7.5 | - | Upgrade
|
| Financing Cash Flow | -1,150 | -1,255 | -11.9 | 75.4 | 44.8 | Upgrade
|
| Net Cash Flow | -140.1 | 489.5 | 246.5 | 66.4 | 156.1 | Upgrade
|
| Free Cash Flow | 1,041 | 1,081 | 747.6 | 663.7 | 477.4 | Upgrade
|
| Free Cash Flow Growth | -3.69% | 44.54% | 12.64% | 39.02% | -31.45% | Upgrade
|
| Free Cash Flow Margin | 32.70% | 37.55% | 32.12% | 34.28% | 28.32% | Upgrade
|
| Free Cash Flow Per Share | 21.73 | 22.28 | 15.04 | 13.69 | 10.09 | Upgrade
|
| Cash Interest Paid | 13.5 | 40.2 | 56 | 29.1 | 16.2 | Upgrade
|
| Cash Income Tax Paid | 313.3 | 400.6 | 332.5 | 275.7 | 153.3 | Upgrade
|
| Levered Free Cash Flow | 582.01 | 830.83 | 609.74 | 506.28 | 406.69 | Upgrade
|
| Unlevered Free Cash Flow | 594.2 | 857.64 | 646.8 | 526.53 | 418.31 | Upgrade
|
| Change in Working Capital | -106.5 | 3.9 | -33.4 | -141.2 | -174.2 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.